SCHEMBL418078

SCHEMBL418078

CC(C)[C@@H](C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2017195 1.00 ALDH1A1 (0.56)
SCHEMBL23875 1.00
SCHEMBL685153 1.00
Hydrochloric Acid SCHEMBL6645496 0.94
SCHEMBL28881845 0.94
SCHEMBL31518532 0.94
SCHEMBL27646234 0.94
Ammonia Solution, Strong SCHEMBL2679632 0.94
Methyl Alcohol SCHEMBL17241953 0.94
Ammonia Solution, Strong SCHEMBL1333597 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 284 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119776301-A Alcohol dehydrogenase, recombinant genetically engineered bacterium and application thereof in asymmetric reduction of potential chiral carbonyl compounds 杭州文德阶生物科技有限公司 2025-04-08 CN claimed
CN-115745764-B Preparation method of milbelin intermediate 重庆华森制药股份有限公司 2024-03-12 CN claimed
CN-115745764-A Preparation method of milobalin intermediate 重庆华森制药股份有限公司 2023-03-07 CN claimed
US-11424006-B2 Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide PSOMAGEN, INC. (US) 2022-08-23 US claimed
US-20210128498-A1 TARGETED DRUGS ASSOCIATED WITH TRIMETHYLAMINE AND/OR TRIMETHYLAMINE-N-OXIDE MACROGEN INC. (KR) 2021-05-06 US claimed
EP-3668494-A1 TARGETED DRUGS ASSOCIATED WITH TRIMETHYLAMINE AND/OR TRIMETHYLAMINE-N-OXIDE Psomagen, Inc. (US) 2020-06-24 EP claimed
CN-111163761-A Targeted drugs related to trimethylamine and/or trimethylamine-N-oxide 普梭梅根公司 2020-05-15 CN claimed
CN-105853472-B A kind of red shellfish essential oil and preparation method 佛山科学技术学院 2019-10-25 CN claimed
WO-2019036507-A1 TARGETED DRUGS ASSOCIATED WITH TRIMETHYLAMINE AND/OR TRIMETHYLAMINE-N-OXIDE uBiome, Inc. (US) 2019-02-21 WO claimed
US-20190050525-A1 RIESKE-TYPE OXYGENASE/REDUCTASE TARGETED DRUGS FOR DIAGNOSTIC AND TREATMENT OF DISEASES PSOMAGEN, INC. 2019-02-14 US claimed
CN-105853472-A Arkshell essential oil and preparation method thereof 佛山科学技术学院 2016-08-17 CN claimed
US-8471067-B2 Stereoselective preparation of P-chiral four-co-ordinated phosphorus compound (o-Tolylphenylmethylphosphine oxide) by reacting chiral alcohol, chiral amine or chiral thiol, with P-chiral three-co-ordinated phosphorus compound, in presence of electrophile UNIVERSITY COLLEGE DUBLIN (IE) 2013-06-25 US claimed
US-20080255391-A1 Chiral Phosphorus Compounds UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND (IE) 2008-10-16 US claimed
JP-2008501010-A 2008-01-17 JP claimed
EP-1751170-A1 CHIRAL PHOSPHORUS COMPOUNDS UNIVERSITY COLLEGE DUBLIN (IE) 2007-02-14 EP claimed
WO-2005118603-A1 CHIRAL PHOSPHORUS COMPOUNDS UNIVERSITY COLLEGE DUBLIN (IE) 2005-12-15 WO claimed
US-20050154216-A1 Novel enantiomeric compounds for treatment of cardiac arrhythmias and methods of use ARYX THERAPEUTICS 2005-07-14 US claimed
EP-4673214-A1 PYRIDAZINYL AMINO DERIVATIVES AS ALK5 INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2026-01-07 EP disclosed
US-4374257-A Novel ethers containing a lactone group and a chiral atom ROUSSEL UCLAF (FR) 1983-02-15 US disclosed
US-4265817-A Novel chiral ethers and their use in resolution of alcohols and phenols ROUSSEL UCLAF (FR) 1981-05-05 US disclosed